Charles Zhu analyst GUGGENHEIM

Currently out of the existing stock ratings of Charles Zhu, 28 are a BUY (90.32%), 3 are a HOLD (9.68%).

Charles Zhu

Work Performance Price Targets & Ratings Chart

Analyst Charles Zhu, currently employed at GUGGENHEIM, has had 63.89% of price targets met with an average potential upside of 54.29%, reached in 340 days on average. Previously, Charles Zhu worked at LIFESCI.

Charles Zhu has documented 59 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRUS, Merus BV at 30-Sep-2025.

Wall Street Analyst Charles Zhu

Analyst best performing recommendations are on MGNX (MACROGENICS).
The best stock recommendation documented was for MGNX (MACROGENICS) on 1/2/2024. The price target of $20 was fulfilled within 62 days with a profit of $9.82 (96.46%), with a performance score of 15.56.

Average potential price target upside

RPTX Repare Therapeutics XNCR Xencor IDYA Ideaya Biosciences MGNX MacroGenics MRUS Merus BV ZYME Zymeworks TNGX Tango Therapeutics COGT Cogent Biosciences PNT POINT Biopharma Global

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Sep-2021

$3

$5

1 years 23 days ago
(28-Oct-2025)

0/19 (0%)

$1.21 (67.60%)

Buy Since 25-Sep-2023

$3

$4

1 years 10 months 10 days ago
(10-Jan-2025)

4/17 (23.53%)

$1.62 (117.39%)

9

Buy Since 28-Jun-2021

$38

1 years 11 months 7 days ago
(13-Dec-2024)

0/3 (0%)

$25.33 (199.92%)

Buy Since 14-Jul-2020

$25

$25

2 years 1 months 19 days ago
(01-Oct-2024)

2/9 (22.22%)

$21.53 (620.46%)

141

Buy Since 17-Mar-2022

$28

$43

3 years 6 months 10 days ago
(10-May-2023)

0/2 (0%)

$17.42 (164.65%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Charles Zhu?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?